Zhang et al. have shown that RECQL1 is expressed at high levels in cisplatin-resistant cancer cell lines derived from moderately-differentiated tongue squamous cell carcinoma, and they proposed that RECQL1 may be associated with the acquisition of cisplatin resistance [19]. This evidence concerns the gene RECQL and tongue squamous cell carcinoma.